These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10894101)

  • 1. Post-inhalation bronchoconstriction by beclomethasone dipropionate: a comparison of two different CFC propellant formulations in asthmatics.
    Ruffin RE; Campbell DA; Chia MM
    Respirology; 2000 Jun; 5(2):125-31. PubMed ID: 10894101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute safety of beclomethasone dipropionate in a new CFC-free propellant system in asthmatic patients.
    Ayres JG; Simmons JL; Stampone P
    Respir Med; 1999 Jan; 93(1):27-32. PubMed ID: 10464845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, safety, and acceptance of beclomethasone dipropionate administered via a new dry powder Inhaler or a standard CFC metered-dose inhaler in asthma patients.
    Kunkel G; Schäper C; Noga O; Schläfke S; Lemmnitz G; Köhler S
    Respiration; 2003; 70(4):399-406. PubMed ID: 14512676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of triamcinolone acetonide MDI with a built-in tube extender and beclomethasone dipropionate MDI in adult asthmatics.
    Berkowitz R; Rachelefsky G; Harris AG; Chen R
    Chest; 1998 Sep; 114(3):757-65. PubMed ID: 9743163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid effects of extrafine beclomethasone dipropionate/formoterol fixed combination inhaler on airway inflammation and bronchoconstriction in asthma: a randomised controlled trial.
    O'Connor BJ; Collarini S; Poli G; Brindicci C; Spinola M; Acerbi D; Barnes PJ; Leaker B
    BMC Pulm Med; 2011 Dec; 11():60. PubMed ID: 22188731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
    Fireman P; Prenner BM; Vincken W; Demedts M; Mol SJ; Cohen RM
    Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of double-strength beclomethasone dipropionate (84 microg) MDI with beclomethasone dipropionate (42 microg) MDI in the treatment of asthma.
    Nathan RA; Nolop KB; Cuss FM; Lorber RR
    Chest; 1997 Jul; 112(1):34-9. PubMed ID: 9228354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic differences between chlorofluorocarbon and chlorofluorocarbon-free metered dose inhalers of beclomethasone dipropionate in adult asthmatics.
    Harrison LI; Soria I; Cline AC; Ekholm BP
    J Pharm Pharmacol; 1999 Nov; 51(11):1235-40. PubMed ID: 10632080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects on lung function, symptoms, and bronchial hyperreactivity of low-dose inhaled beclomethasone dipropionate given with HFA-134a or CFC propellant.
    Woodcock A; Williams A; Batty L; Masterson C; Rossetti A; Cantini L
    J Aerosol Med; 2002; 15(4):407-14. PubMed ID: 12581507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study.
    Wolthers OD; Walters EG
    Clin Ther; 2011 Aug; 33(8):1069-76. PubMed ID: 21784529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the Easibreathe inhaler for the treatment of paediatric asthma.
    Farmer IS; Middle M; Savic J; Perri VL; Herdman MJ
    Respir Med; 2000 Jan; 94(1):57-63. PubMed ID: 10714480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term growth and adrenal function in children with asthma treated with inhaled beclomethasone dipropionate hydrofluoroalkane-134a.
    Wolthers OD
    Pediatr Allergy Immunol; 2006 Dec; 17(8):613-9. PubMed ID: 17121590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equivalence of asthma control with new CFC-free formulation HFA-134a beclomethasone dipropionate and CFC-beclomethasone dipropionate.
    Dahl R; Ringdal N; Ward SM; Stampone P; Donnell D
    Br J Clin Pract; 1997; 51(1):11-5. PubMed ID: 9158265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
    Chrousos GP; Ghaly L; Shedden A; Iezzoni DG; Harris AG
    Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of low doses (50 and 100 microg b.i.d) of beclomethasone dipropionate delivered as a CFC-free extrafine aerosol in adults with mild to moderate asthma. Study Group.
    Hampel F; Lisberg E; Guérin JC
    J Asthma; 2000 Aug; 37(5):389-98. PubMed ID: 10983616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new HFA-134a propellant in the administration of inhaled BDP via the Jet spacer: controlled clinical trial vs the conventional CFC.
    Vondra V; Sladek K; Kotasová J; Terl M; Rossetti A; Cantini L
    Respir Med; 2002 Oct; 96(10):784-9. PubMed ID: 12412977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled beclomethasone (BDP) with non-CFC propellant (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma.
    Milanowski J; Qualtrough J; Perrin VL
    Respir Med; 1999 Apr; 93(4):245-51. PubMed ID: 10464888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placebo-controlled, comparative study of the efficacy and safety of triamcinolone acetonide inhalation aerosol with the non-CFC propellant HFA-134a in patients with asthma. Azmacort HFA Clinical Study Group.
    Jacobson K; Chervinsky P; Noonan M; Kane RE; Banerji D; Uryniak T
    Ann Allergy Asthma Immunol; 1999 Oct; 83(4):327-33. PubMed ID: 10541425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equivalent efficacy and safety of a new HFA-134a formulation of BDP compared with the conventional CFC in adult asthmatics.
    Anderson PB; Langley SJ; Mooney P; Jones J; Addlestone R; Rossetti A; Cantini L
    J Investig Allergol Clin Immunol; 2002; 12(2):107-13. PubMed ID: 12371526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of changing from chlorofluorocarbon (CFC)-beclomethasone dipropionate (BDP) to hydrofluoroalkane (HFA)-BDP on pulmonary function in asthmatic children].
    Yoshida Y; Inoue T; Nishikido T; Kameda M; Takamatu I; Doi S
    Arerugi; 2007 Dec; 56(12):1502-9. PubMed ID: 18195554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.